TISIDB: An integrated repository portal for tumor-immune system interactions
Bioinformatics, ISSN: 1460-2059, Vol: 35, Issue: 20, Page: 4200-4202
2019
- 1,483Citations
- 176Captures
- 10Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1,483
- Citation Indexes1,483
- 1,483
- 1,173
- CrossRef709
- Captures176
- Readers176
- 176
- Mentions10
- News Mentions10
- 10
Most Recent News
Identification of EARS2 as a Potential Biomarker with Diagnostic, Prognostic, and Therapeutic Implications in Colorectal Cancer
Introduction Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and is the second leading cause of cancer-related mortality.1 Despite advancements in early
Article Description
The interaction between tumor and immune system plays a crucial role in both cancer development and treatment response. To facilitate comprehensive investigation of tumor immune interactions, we have designed a user-friendly web portal TISIDB, which integrated multiple types of data resources in oncoimmunology. First, we manually curated 4176 records from 2530 publications, which reported 988 genes related to anti-tumor immunity. Second, genes associated with the resistance or sensitivity of tumor cells to T cell-mediated killing and immunotherapy were identified by analyzing high-throughput screening and genomic profiling data. Third, associations between any gene and immune features, such as lymphocytes, immunomodulators and chemokines, were precalculated for 30 TCGA cancer types. In TISIDB, biologists can cross-check a gene of interest about its role in tumor immune interactions through literature mining and high-throughput data analysis, and generate testable hypotheses and high quality figures for publication.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85071048049&origin=inward; http://dx.doi.org/10.1093/bioinformatics/btz210; http://www.ncbi.nlm.nih.gov/pubmed/30903160; https://academic.oup.com/bioinformatics/article/35/20/4200/5418799; https://dx.doi.org/10.1093/bioinformatics/btz210
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know